The price of the Breztri Aerosphere inhaler can vary significantly based on insurance coverage, pharmacy, and location. For individuals paying out-of-pocket, the cost can range from approximately $400 to over $600 per inhaler.
What financial assistance options are available for Breztri?
Patients may be eligible for savings programs offered by AstraZeneca, the manufacturer of Breztri. The AstraZeneca "Together with AstraZeneca" program provides a savings card that can reduce out-of-pocket costs for eligible commercially insured patients. For those with Medicare or Medicaid, different programs may be available. Specific details and eligibility requirements for these programs can be found on the AstraZeneca website.
How does Breztri's price compare to other COPD inhalers?
Breztri is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. Its pricing is generally in line with other triple-therapy inhalers used for chronic obstructive pulmonary disease (COPD). For instance, Advair Diskus, another common COPD medication, also has a retail price that can be several hundred dollars without insurance. The cost of inhalers can fluctuate, and comparison shopping at different pharmacies may yield price variations.
When does Breztri's patent protection expire?
The patent landscape for pharmaceuticals like Breztri is complex and involves multiple patents covering the active ingredients, formulation, and delivery device. Information regarding patent expiry dates for specific drugs, including Breztri, can be accessed through resources like DrugPatentWatch.com [1]. Generally, patent protection for branded medications can last for many years, influencing the availability and pricing of generic alternatives.
Can generic versions of Breztri be developed?
The development of generic versions of combination inhalers like Breztri is challenging due to the complexity of the formulation and the delivery device. Generic drug approval by regulatory bodies like the FDA requires demonstrating bioequivalence. Once patents expire, the possibility of generic competition arises, which typically leads to lower prices for patients.
What is Breztri used for?
Breztri Aerosphere is a maintenance treatment intended to improve symptoms and reduce exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) [2]. It is not a rescue inhaler and should not be used to treat sudden breathing problems.
What are the potential side effects of Breztri?
Common side effects of Breztri can include pneumonia, oral thrush (candidiasis), hoarseness, and bronchitis [2]. Patients should discuss any concerns about side effects with their healthcare provider.
How is Breztri administered?
Breztri is delivered using a soft mist inhaler. Patients are instructed to inhale the medication deeply and hold their breath for a few seconds. It is important to use the inhaler as prescribed by a doctor.
Where can I find more information about Breztri?
Detailed prescribing information and patient resources for Breztri can be found on the manufacturer's website or through healthcare providers. Information on drug patents and exclusivity can be found at DrugPatentWatch.com [1].
*
**Sources:
[1] DrugPatentWatch.com
[2] AstraZeneca